phosphorylcholine has been researched along with Graft Occlusion, Vascular in 7 studies
Phosphorylcholine: Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
phosphocholine : The phosphate of choline; and the parent compound of the phosphocholine family.
Graft Occlusion, Vascular: Obstruction of flow in biological or prosthetic vascular grafts.
Excerpt | Relevance | Reference |
---|---|---|
"This study attempts to prevent neointimal hyperplasia by coating the graft luminal surface with a derivative of phosphorylcholine (PC), thereby providing a biocompatible surface with the assumption of limiting pannus tissue ingrowth from the graft anastomoses." | 7.69 | Phosphorylcholine coating of ePTFE grafts reduces neointimal hyperplasia in canine model. ( Campbell, EJ; Chen, C; Hanson, SR; Lumsden, AB; Noe, B; Ofenloch, JC; Stratford, PW; Taylor, AS; Yianni, YP, 1997) |
"This study attempts to prevent neointimal hyperplasia by coating the graft luminal surface with a derivative of phosphorylcholine (PC), thereby providing a biocompatible surface with the assumption of limiting pannus tissue ingrowth from the graft anastomoses." | 3.69 | Phosphorylcholine coating of ePTFE grafts reduces neointimal hyperplasia in canine model. ( Campbell, EJ; Chen, C; Hanson, SR; Lumsden, AB; Noe, B; Ofenloch, JC; Stratford, PW; Taylor, AS; Yianni, YP, 1997) |
" Further study is necessary to determine the dose-response and long-term effects ABT-578-eluting stents in the porcine coronary model." | 1.33 | Stent-based delivery of ABT-578 via a phosphorylcholine surface coating reduces neointimal formation in the porcine coronary model. ( Carter, AJ; Collingwood, R; Gibson, L; Sedlik, S; Virmani, R, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sobel, M | 2 |
Yagi, M | 2 |
Moreno, K | 1 |
Kohler, TR | 2 |
Tang, GL | 2 |
Wijelath, ES | 1 |
Marshall, J | 1 |
Kenagy, RD | 1 |
Moreno, KI | 1 |
Clowes, AW | 1 |
Zhou, XH | 1 |
Eugenio, E | 1 |
Swanson, N | 1 |
Javed, Q | 1 |
Hogrefe, K | 1 |
Gershlick, A | 1 |
Collingwood, R | 1 |
Gibson, L | 1 |
Sedlik, S | 1 |
Virmani, R | 1 |
Carter, AJ | 1 |
Faria-Neto, JR | 1 |
Chyu, KY | 1 |
Li, X | 1 |
Dimayuga, PC | 1 |
Ferreira, C | 1 |
Yano, J | 1 |
Cercek, B | 1 |
Shah, PK | 1 |
Chan, KH | 1 |
Armstrong, J | 1 |
Withers, S | 1 |
Malik, N | 1 |
Cumberland, DC | 1 |
Gunn, J | 1 |
Holt, CM | 1 |
Chen, C | 1 |
Lumsden, AB | 1 |
Ofenloch, JC | 1 |
Noe, B | 1 |
Campbell, EJ | 1 |
Stratford, PW | 1 |
Yianni, YP | 1 |
Taylor, AS | 1 |
Hanson, SR | 1 |
7 other studies available for phosphorylcholine and Graft Occlusion, Vascular
Article | Year |
---|---|
Anti-phosphorylcholine IgM, an Anti-inflammatory Mediator, Predicts Peripheral Vein Graft Failure: A Prospective Observational Study.
Topics: Aged; Aged, 80 and over; Autografts; Female; Graft Occlusion, Vascular; Graft Rejection; Humans; Imm | 2019 |
Low levels of a natural IgM antibody are associated with vein graft stenosis and failure.
Topics: Aged; Aged, 80 and over; Atherosclerosis; Biomarkers; Constriction, Pathologic; Down-Regulation; Fem | 2013 |
Human internal mammary artery organ culture model of coronary stenting: a novel investigation of smooth muscle cell response to drug-eluting stents.
Topics: Cell Division; Coated Materials, Biocompatible; Coronary Artery Disease; Drug Delivery Systems; Graf | 2002 |
Stent-based delivery of ABT-578 via a phosphorylcholine surface coating reduces neointimal formation in the porcine coronary model.
Topics: Angioplasty, Balloon, Coronary; Animals; Coated Materials, Biocompatible; Coronary Vessels; Disease | 2005 |
Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice.
Topics: Animals; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Apolipoproteins E; Atherosclerosis; Car | 2006 |
Vascular delivery of c-myc antisense from cationically modified phosphorylcholine coated stents.
Topics: Animals; Blood Vessel Prosthesis; Coated Materials, Biocompatible; DNA-Binding Proteins; DNA, Antise | 2007 |
Phosphorylcholine coating of ePTFE grafts reduces neointimal hyperplasia in canine model.
Topics: Animals; Biocompatible Materials; Blood Vessel Prosthesis; Carotid Arteries; Cell Division; Dogs; Gr | 1997 |